Thousand Oaks Biologics at CPHI Frankfurt 2025
Thousand Oaks Biologics, a leading Asia-based CRDMO, announced its participation in CPHI Frankfurt 2025, held from October 28-30.
The company will showcase its integrated service platform, supported by industrial media supply and driven by AI and innovative drug discovery technologies at Booth 4.1H54 in the Bioproduction Zone.
Antibody-drug conjugates (ADCs) are a key driver of China's innovative drug globalization.
- Event: CPHI Frankfurt 2025
- Date: October 28-30
- Booth: 4.1H54 in the Bioproduction Zone
Author's summary: Thousand Oaks Biologics participates in CPHI Frankfurt 2025.
More News
- ‘Like It Was Yesterday’: The 1985 Villanova Football Team Reunited For Its 40th Anniversary
- 5 principles for our once-in-a-generation reset on inclusion
- Gmail Data Breach: 183 million accounts exposed in massive leak
- Vietnam Draft AI Law: Regulatory Milestone and Business Implications
- Landmark New Report Shows Canadian Lobbyists Represent Major Polluters Alongside Environmental Groups
- Elaine Hendrix on Vegan Living, ‘Dancing With the Stars’, and Life After ‘The Parent Trap’
- China Bistro Ignites Ealing with Tangra Spice and 50% Off Food
- Chicago-area Transit crisis: 7 principles to guide Illinois transportation reform
- Hugo Rodrigues: A nine-member Cornwall city council? That's disappointing
- Man hospitalized after South Miami-Dade home catches fire overnight - WSVN 7News | Miami News, Weather, Sports | Fort Lauderdale